Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
156.97
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quest Diagnostics
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are...
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard
August 28, 2023
Via
ACCESSWIRE
Quest Diagnostics: Dividend Insights
July 05, 2023
Via
Benzinga
Analyst Ratings for Quest Diagnostics
June 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Quest Diagnostics
May 02, 2023
Via
Benzinga
Will Chart Analysts Notice Bad Omen on Quest Diagnostics's Chart
May 02, 2023
Via
Benzinga
3 Pharma Stocks to Buy as Summer COVID Cases Spike
August 23, 2023
Covid cases are on the rise, which might be the booster shot these top pharma stocks for Covid need to regain their trajectory.
Via
InvestorPlace
Exposures
COVID-19
Why Bionano Genomics Stock Tanked Today
August 14, 2023
A CFO departure shines a light on some of the company's recent struggles.
Via
The Motley Fool
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
August 09, 2023
Alzheimer's is a huge problem, and earlier detection could make a big difference.
Via
The Motley Fool
Looking for a Bargain? 3 Stocks to Buy That Are Down 10% in 2023
August 02, 2023
Investors looking for bargain stock opportunities in a rapidly-rising market should consider these companies that haven't yet bounced back.
Via
InvestorPlace
Quest Diagnostics Stock Falls on Lower Q2 Revenue and Profits from Lower Productivity Effects, Tightened Outlook
July 26, 2023
Quest Diagnostics Inc (NYSE: DGX) posted Q2 FY23 adjusted EPS of $2.30, down 2.5% Y/Y, beating the consensus of $2.27.
Via
Benzinga
Sustaining Growth Momentum: Quest Diagnostics Continues to Excel and Reports Rising Profits
July 25, 2023
At the end of July 25, 2023, Quest Diagnostics (NYSE:DGX) will reward its shareholders with a dividend payout of $0.71 per share, demonstrating an annualized dividend yield of 2.15%. Remember, only...
Via
Benzinga
Quest Diagnostics Q1 Earnings Surpass Expectations; COVID-19 Testing Revenues Slump 80%
April 27, 2023
Via
Benzinga
Analyst Expectations for Quest Diagnostics's Future
April 03, 2023
Via
Benzinga
Analyst Expectations for Quest Diagnostics's Future
March 17, 2023
Via
Benzinga
Quest Diagnostics, Keysight Technologies And A Stock Up 42% Year To Date On CNBC's 'Final Trades'
July 19, 2023
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes Quest Diagnostics Incorporated (NYSE: DGX) here.
Via
Benzinga
Biden Administration Releases Revised Guidance For Medicare Drug Price Negotiation Amid Industry Lawsuits
June 30, 2023
The Centers for Medicare and Medicaid Services released revised guidance on using its authority with pharmaceutical manufacturers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
June 29, 2023
Via
Benzinga
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
June 08, 2023
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a...
Via
Benzinga
Want Growing Passive Income? Consider Buying This Stock
May 24, 2023
This maker of diagnostics tests has delivered 13 years of dividend growth to shareholders.
Via
The Motley Fool
Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds
May 18, 2023
The percentage of employees in the general U.S. workforce testing positive for marijuana following an on-the-job accident increased to its highest level in 25 years in 2022, according to a new analysis...
Via
Benzinga
Exact Sciences Serves Investors Exactly What They Wished For
May 15, 2023
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The
Via
MarketBeat
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
May 11, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
May 02, 2023
Via
Benzinga
UiPath is a Cheaper and More Profitable AI Stock
April 06, 2023
With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session
March 24, 2023
Via
Investor Brand Network
Is This Healthcare Stock a Buy for Dividend Growth Investors?
March 07, 2023
This maker of diagnostics tests just announced that it will be sending more cash to its shareholders.
Via
The Motley Fool
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%
February 15, 2023
These companies may not be finished raising their dividend payments as they both have low payout ratios.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.